HSA grants interim authorisation for Pfizer-BioNTech Covid-19 vaccine in Singapore

  • 📰 BusinessTimes
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Business Business Headlines News

Business Business Latest News,Business Business Headlines

THE Health Sciences Authority (HSA) has on Monday given the green light for the Pfizer-BioNTech Covid-19 vaccine to be used in Singapore, for the prevention of Covid-19. Read more at The Business Times.

THE Health Sciences Authority has on Monday given the green light for the Pfizer-BioNTech Covid-19 vaccine to be used in Singapore, for the prevention of Covid-19. In view of the HSA's approval, the Expert Committee on Covid-19 Vaccination appointed by the Ministry of Health has.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 15. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

EU regulator set to approve Pfizer/BioNTech COVID-19 vaccine on December 23The European Medicines Agency (EMA) is set to approve its first COVID-19 vaccine on Dec. 23, a German government source told Reuters on Tuesday, putting EU countries on track to start to catch up with the United States and Britain, where immunisation campaigns are under way. 'Yes, the EMA will be done on December 23,' the source said, referring to the watchdog's review of a vaccine developed by U.S. company Pfizer and its German partner BioNTech. German Health Minister Jens Spahn told a news conference that he hoped European Union approval for the vaccine would be in place before Christmas, clearing a path for innoculations before the end of the year.
Source: YahooSG - 🏆 3. / 71 Read more »